Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,964.00
(
-0.21%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.98
(
2.72%
)
Bitcoin
73,754.00
(
-1.46%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

kris_kade

Send PM Follow Ignore
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

kris_kade

Re: DewDiligence post# 217668

Sunday, 03/04/2018 7:08:45 PM

Sunday, March 04, 2018 7:08:45 PM

Post# of 257250
Good that Sakura-3 is open label; so investors can track any safety issue.

The long trials that Revance has gone thru speaks loud as how high the bar is when it comes to ‘Botox’ approval.

I just hope they keep their laser focus on getting BLA filed as quickly as possible. Execution, execution and execution. Biosimilars can wait.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now